134.06
price down icon1.64%   -2.24
after-market アフターアワーズ: 132.00 -2.06 -1.54%
loading
前日終値:
$136.30
開ける:
$136.495
24時間の取引高:
7.98M
Relative Volume:
1.25
時価総額:
$166.40B
収益:
$29.45B
当期純損益:
$8.51B
株価収益率:
19.77
EPS:
6.7823
ネットキャッシュフロー:
$9.46B
1週間 パフォーマンス:
+2.46%
1か月 パフォーマンス:
-3.41%
6か月 パフォーマンス:
+12.81%
1年 パフォーマンス:
+35.55%
1日の値動き範囲:
Value
$133.76
$136.50
1週間の範囲:
Value
$129.01
$136.75
52週間の値動き範囲:
Value
$95.30
$157.29

Gilead Sciences Inc Stock (GILD) Company Profile

Name
名前
Gilead Sciences Inc
Name
セクター
Healthcare (1107)
Name
電話
(650) 574-3000
Name
住所
333 LAKESIDE DR, FOSTER CITY, CA
Name
職員
17,000
Name
Twitter
@GileadSciences
Name
次回の収益日
2026-05-07
Name
最新のSEC提出書
Name
GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, AZN, NVS

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GILD icon
GILD
Gilead Sciences Inc
134.06 169.18B 29.45B 8.51B 9.46B 6.7823
LLY icon
LLY
Lilly Eli Co
974.96 880.19B 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
222.51 540.71B 96.36B 21.04B 17.80B 8.6488
ABBV icon
ABBV
Abbvie Inc
202.71 362.65B 62.82B 3.62B 17.82B 2.0331
AZN icon
AZN
Astrazeneca Plc
182.52 286.78B 60.48B 10.40B 8.05B 3.3297
NVS icon
NVS
Novartis Ag Adr
145.39 283.08B 54.66B 13.58B 16.05B 7.0171

Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-10 開始されました Jefferies Buy
2026-02-20 開始されました Barclays Equal Weight
2026-02-11 繰り返されました Needham Buy
2026-01-07 再開されました UBS Buy
2025-11-24 再開されました Truist Buy
2025-11-13 開始されました Scotiabank Sector Outperform
2025-08-19 アップグレード Daiwa Securities Neutral → Outperform
2025-08-08 アップグレード Truist Hold → Buy
2025-07-25 アップグレード Needham Hold → Buy
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-03-04 繰り返されました Oppenheimer Outperform
2025-02-18 アップグレード Deutsche Bank Hold → Buy
2025-02-13 アップグレード DZ Bank Hold → Buy
2025-01-10 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました BofA Securities Buy
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Buy
2024-11-08 ダウングレード Maxim Group Buy → Hold
2024-10-21 アップグレード Leerink Partners Market Perform → Outperform
2024-10-17 開始されました Bernstein Outperform
2024-10-07 アップグレード Wells Fargo Equal Weight → Overweight
2024-07-08 アップグレード Raymond James Mkt Perform → Outperform
2024-05-01 繰り返されました Maxim Group Buy
2024-04-24 アップグレード HSBC Securities Reduce → Hold
2024-02-22 ダウングレード Truist Buy → Hold
2023-11-09 開始されました Deutsche Bank Hold
2023-09-08 アップグレード BofA Securities Neutral → Buy
2023-09-06 開始されました HSBC Securities Reduce
2023-07-24 繰り返されました Barclays Equal Weight
2023-05-16 アップグレード BMO Capital Markets Market Perform → Outperform
2023-04-28 再開されました Piper Sandler Overweight
2023-01-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-12-13 再開されました BofA Securities Neutral
2022-12-09 ダウングレード DZ Bank Buy → Hold
2022-10-31 アップグレード Barclays Underweight → Equal Weight
2022-10-28 繰り返されました BMO Capital Markets Market Perform
2022-10-28 繰り返されました Cowen Outperform
2022-10-28 繰り返されました JP Morgan Overweight
2022-10-28 繰り返されました Jefferies Buy
2022-10-28 アップグレード Piper Sandler Neutral → Overweight
2022-10-28 繰り返されました RBC Capital Mkts Outperform
2022-10-28 アップグレード Truist Hold → Buy
2022-10-28 繰り返されました Wells Fargo Equal Weight
2022-10-04 アップグレード JP Morgan Neutral → Overweight
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-28 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-02-02 繰り返されました BMO Capital Markets Outperform
2022-02-02 繰り返されました BofA Securities Neutral
2022-02-02 繰り返されました RBC Capital Mkts Outperform
2022-02-02 繰り返されました Truist Hold
2022-02-02 繰り返されました Wells Fargo Equal Weight
2022-01-28 アップグレード Argus Hold → Buy
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Neutral
2021-11-19 アップグレード BMO Capital Markets Market Perform → Outperform
2021-11-19 再開されました Piper Sandler Neutral
2021-10-20 再開されました Cowen Outperform
2021-07-30 繰り返されました BMO Capital Markets Market Perform
2021-07-30 繰り返されました RBC Capital Mkts Outperform
2021-04-01 アップグレード Bernstein Mkt Perform → Outperform
2021-03-30 アップグレード Redburn Neutral → Buy
2021-01-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-01-04 アップグレード Guggenheim Neutral → Buy
2020-11-03 再開されました Morgan Stanley Equal-Weight
2020-10-28 開始されました UBS Neutral
2020-09-30 再開されました Jefferies Buy
2020-09-15 アップグレード Maxim Group Hold → Buy
2020-07-31 繰り返されました Credit Suisse Neutral
2020-07-31 繰り返されました Morgan Stanley Equal-Weight
2020-07-31 繰り返されました Piper Sandler Overweight
2020-07-31 繰り返されました RBC Capital Mkts Outperform
2020-07-31 繰り返されました SunTrust Hold
2020-07-31 繰り返されました Wells Fargo Equal Weight
2020-07-20 アップグレード Credit Suisse Underperform → Neutral
2020-06-03 アップグレード SVB Leerink Mkt Perform → Outperform
2020-05-26 アップグレード SunTrust Sell → Hold
2020-05-01 ダウングレード JP Morgan Overweight → Neutral
2020-05-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-05-01 ダウングレード SunTrust Hold → Sell
2020-04-27 ダウングレード UBS Buy → Neutral
2020-04-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-04-20 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 ダウングレード CFRA Hold → Sell
すべてを表示

Gilead Sciences Inc (GILD) 最新ニュース

pulisher
07:02 AM

Gilead Sciences, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:GILD) 2026-05-07 - Seeking Alpha

07:02 AM
pulisher
06:33 AM

Gilead Stock Falls. A Massive Acquisition Spree Is Coming at a Cost. - Barron's

06:33 AM
pulisher
06:22 AM

Will Anito-Cel Rescue Gilead’s Cell Therapy Business? - Citeline News & Insights

06:22 AM
pulisher
06:18 AM

Gilead slips despite Q1 beats as it now expects 2026 loss per share - MSN

06:18 AM
pulisher
06:00 AM

Gilead (GILD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore

06:00 AM
pulisher
05:22 AM

Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions - Reuters

05:22 AM
pulisher
05:15 AM

Gilead Sciences (GILD) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance UK

05:15 AM
pulisher
05:07 AM

Gilead Sciences falls 4% as acquired IPR&D charges impact full-year earnings guidance - Investing.com Nigeria

05:07 AM
pulisher
05:04 AM

Gilead Lifted Its Sales View, But 2026 Earnings Took A Hit - Finimize

05:04 AM
pulisher
05:00 AM

Gilead Sciences expects loss this year on acquired R&D expenses - MSN

05:00 AM
pulisher
04:47 AM

Gilead Sciences (NASDAQ:GILD) Issues FY 2026 Earnings Guidance - MarketBeat

04:47 AM
pulisher
04:41 AM

Gilead Sciences Inc (NASDAQ:GILD) Beats Q1 Estimates But Stock Falls on Hefty Acquisition Costs and Revised Loss Guidance - ChartMill

04:41 AM
pulisher
04:39 AM

Gilead Sciences Expects Loss This Year on Acquired R&D Expenses - WSJ

04:39 AM
pulisher
04:38 AM

Gilead Sciences’s (NASDAQ:GILD) Q1 CY2026: Beats On Revenue - StockStory

04:38 AM
pulisher
04:32 AM

Earnings snapshot: Gilead beats Q1 estimates but guides for FY26 loss - MSN

04:32 AM
pulisher
04:32 AM

GILEAD SCIENCES ($GILD) Releases Q1 2026 Earnings - Quiver Quantitative

04:32 AM
pulisher
04:13 AM

Gilead Sciences Q1 Adjusted Earnings, Revenue Rise; Lowers Full-Year EPS Guidance - marketscreener.com

04:13 AM
pulisher
04:09 AM

(GILD) Gilead Sciences Now Expects 2026 Adjusted Loss Per Share Range $1.05-$0.65, vs. FactSet Est for EPS of $8.55 - marketscreener.com

04:09 AM
pulisher
04:09 AM

Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions By Reuters - Investing.com

04:09 AM
pulisher
04:08 AM

Gilead Tumbles On Mixed Guidance Update Amid Recent M&A Frenzy - Investor's Business Daily

04:08 AM
pulisher
04:05 AM

Gilead Raises 2026 Sales Forecast, Cuts Profit Outlook Due to Acquisitions - U.S. News Money

04:05 AM
pulisher
04:04 AM

Earnings Flash (GILD) Gilead Sciences, Inc. Posts Q1 Adjusted EPS $2.03 per Share - marketscreener.com

04:04 AM
pulisher
04:03 AM

Earnings Flash (GILD) Gilead Sciences Posts Q1 Revenue $7B, vs. FactSet Est of $6.91B - marketscreener.com

04:03 AM
pulisher
04:02 AM

Gilead Sees 2026 Loss on $11.5 Billion in Deal-Related Costs - Bloomberg.com

04:02 AM
pulisher
04:01 AM

Gilead Sciences Announces First Quarter Financial Results - Yahoo Finance

04:01 AM
pulisher
04:00 AM

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewswire Inc.

04:00 AM
pulisher
03:31 AM

Gilead earnings up next: Can Yeztugo deliver after buyout blitz? By Investing.com - Investing.com Nigeria

03:31 AM
pulisher
03:29 AM

Gilead earnings up next: Can Yeztugo deliver after buyout blitz? - Investing.com

03:29 AM
pulisher
03:17 AM

Gilead Accuses Pharmacies Of Selling Counterfeit HIV Drugs - Law360

03:17 AM
pulisher
01:10 AM

Gilead Sciences shares decline 1.36% ahead of first quarter earnings - Mint

01:10 AM
pulisher
10:45 AM

Gilead guides for earnings loss after M&A mania, but bumps up sales expectations - FirstWord Pharma

10:45 AM
pulisher
10:42 AM

Gilead wipes out most of Arcellx workforce - BioSpace

10:42 AM
pulisher
10:08 AM

A Look At Gilead Sciences (GILD) Valuation After FDA Priority Review For New HIV Tablet - simplywall.st

10:08 AM
pulisher
09:06 AM

WealthShield Partners LLC Takes $1.73 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

09:06 AM
pulisher
08:53 AM

Lilly, Gilead lead pharma’s M&A boom - Pharma Voice

08:53 AM
pulisher
07:56 AM

Gilead Sciences Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead - Benzinga

07:56 AM
pulisher
04:33 AM

Indivisible Partners Purchases New Stake in Gilead Sciences, Inc. $GILD - MarketBeat

04:33 AM
pulisher
03:12 AM

Alecta Tjanstepension Omsesidigt Makes New $99.95 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat

03:12 AM
pulisher
01:02 AM

California court weighs forcing Gilead to invest in safer HIV drugs - mezha.net

01:02 AM
pulisher
May 06, 2026

7 months after last layoffs, Bay Area biotech giant does another round - SFGATE

May 06, 2026
pulisher
May 06, 2026

California Justices Scrutinize Gilead Patients’ Liability Theory - Bloomberg Law News

May 06, 2026
pulisher
May 06, 2026

Bay Area biotech takes another hit as Gilead announces major job cuts - SFGATE

May 06, 2026
pulisher
May 06, 2026

California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' - Reuters

May 06, 2026
pulisher
May 06, 2026

Airbnb, McKesson, Gilead and more set to report earnings Thursday By Investing.com - Investing.com Nigeria

May 06, 2026
pulisher
May 06, 2026

Airbnb, McKesson, Gilead and more set to report earnings Thursday - Investing.com

May 06, 2026
pulisher
May 06, 2026

Gilead Sciences Q1 2026 Earnings Preview: Steady growth ahead? (GILD:NASDAQ) - Seeking Alpha

May 06, 2026
pulisher
May 06, 2026

Can We End the HIV Epidemic Once and for All? This Researcher Thinks So. - Men's Health

May 06, 2026
pulisher
May 06, 2026

Madrigal MASH drug beats expectations; Gilead cuts jobs; investment firm debuts - Endpoints News

May 06, 2026
pulisher
May 06, 2026

Gilead to lay off dozens in Rockville after closing Arcellx acquisition - The Business Journals

May 06, 2026
pulisher
May 06, 2026

Swedbank AB Buys 43,205 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

May 06, 2026
pulisher
May 06, 2026

Mitsubishi UFJ Asset Management Co. Ltd. Acquires 129,186 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

May 06, 2026

Gilead Sciences Inc (GILD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$329.09
price down icon 0.61%
PFE PFE
$26.48
price down icon 0.19%
NVO NVO
$45.80
price up icon 0.09%
MRK MRK
$112.30
price down icon 1.11%
NVS NVS
$145.39
price down icon 2.00%
大文字化:     |  ボリューム (24 時間):